394 related articles for article (PubMed ID: 26134973)
1. Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.
Wee CW; Sung W; Kang HC; Cho KH; Han TJ; Jeong BK; Jeong JU; Kim H; Kim IA; Kim JH; Kim SH; Kim S; Lee DS; Lee MY; Lim DH; Park HL; Suh CO; Yoon SM; Kim IH
Radiat Oncol; 2015 Jul; 10():137. PubMed ID: 26134973
[TBL] [Abstract][Full Text] [Related]
2. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
3. NRG brain tumor specialists consensus guidelines for glioblastoma contouring.
Kruser TJ; Bosch WR; Badiyan SN; Bovi JA; Ghia AJ; Kim MM; Solanki AA; Sachdev S; Tsien C; Wang TJC; Mehta MP; McMullen KP
J Neurooncol; 2019 May; 143(1):157-166. PubMed ID: 30888558
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.
Baldini EH; Abrams RA; Bosch W; Roberge D; Haas RLM; Catton CN; Indelicato DJ; Olsen JR; Deville C; Chen YL; Finkelstein SE; DeLaney TF; Wang D
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1053-1059. PubMed ID: 26194680
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.
Baldini EH; Bosch W; Kane JM; Abrams RA; Salerno KE; Deville C; Raut CP; Petersen IA; Chen YL; Mullen JT; Millikan KW; Karakousis G; Kendrick ML; DeLaney TF; Wang D
Ann Surg Oncol; 2015 Sep; 22(9):2846-52. PubMed ID: 26018727
[TBL] [Abstract][Full Text] [Related]
6. Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.
Tseng CL; Stewart J; Whitfield G; Verhoeff JJC; Bovi J; Soliman H; Chung C; Myrehaug S; Campbell M; Atenafu EG; Heyn C; Das S; Perry J; Ruschin M; Sahgal A
J Neurooncol; 2020 Sep; 149(2):305-314. PubMed ID: 32860571
[TBL] [Abstract][Full Text] [Related]
7. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity.
Bahig H; Roberge D; Bosch W; Levin W; Petersen I; Haddock M; Freeman C; Delaney TF; Abrams RA; Indelicato DJ; Baldini EH; Hitchcock Y; Kirsch DG; Kozak KR; Wolfson A; Wang D
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):298-303. PubMed ID: 23474110
[TBL] [Abstract][Full Text] [Related]
8. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.
Chang EL; Akyurek S; Avalos T; Rebueno N; Spicer C; Garcia J; Famiglietti R; Allen PK; Chao KS; Mahajan A; Woo SY; Maor MH
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):144-50. PubMed ID: 17306935
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation.
Mazzara GP; Velthuizen RP; Pearlman JL; Greenberg HM; Wagner H
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):300-12. PubMed ID: 15093927
[TBL] [Abstract][Full Text] [Related]
11. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-based target volume delineation in radiation therapy treatment planning for brain tumors using localized region-based active contour.
Aslian H; Sadeghi M; Mahdavi SR; Babapour Mofrad F; Astarakee M; Khaledi N; Fadavi P
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):195-201. PubMed ID: 23920396
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
Cardenas CE; Blinde SE; Mohamed ASR; Ng SP; Raaijmakers C; Philippens M; Kotte A; Al-Mamgani AA; Karam I; Thomson DJ; Robbins J; Newbold K; Fuller CD; Terhaard C
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):426-436. PubMed ID: 35124134
[TBL] [Abstract][Full Text] [Related]
15. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
16. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
17. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
18. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
[TBL] [Abstract][Full Text] [Related]
19. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
Wee CW; An HJ; Kang HC; Kim HJ; Wu HG
Technol Cancer Res Treat; 2018 Jan; 17():1533033818787383. PubMed ID: 30012039
[TBL] [Abstract][Full Text] [Related]
20. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
